| (INR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 1.67B | — |
| Operating expense | — | — |
| Net income | 159.81M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, TATVA.NS returned +46.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +21.2% |
| 1 year | +46.1% |
| 5 years | -21.7% |
| All-time high | ₹2,655.75 (Dec 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₹1,000 in TATVA.NS would be worth today ›Yes. Tatva Chintan Pharma Chem Limited paid 1 dividend over the past 12 months. The most recent was ₹1.00 per share on Sep 12, 2025. The dividend yield is 0.06%.
Tatva Chintan Pharma Chem Limited is part of the Basic Materials sector.
Tatva Chintan Pharma Chem Limited has a market cap of 37.56B INR, based on the latest quote.
